Market Place
Sourcing Support
DRL, Zydus Recall Drugs In US Over Manufacturing Issues
13 Oct 2025 //
ECONOMICTIMES
USFDA ends inspection at Zydus` oncology plant in Ahmedabad
20 Jun 2025 //
INDPHARMAPOST
USFDA inspection at Zydus` API Unit in Dabhasa, Gujarat ends
29 Apr 2025 //
INDPHARMAPOST
Zydus gets 6 observations from USFDA for API unit
26 Apr 2025 //
ECONOMICTIMES
Supreme Court Asks Zydus to Approach Delhi HC Over Sigrima Ban
19 Nov 2024 //
ECONOMICTIMES
High Court reinstates Injunction stopping sale of Zydus’ Sigrima
29 Oct 2024 //
EXPRESSPHARMA
FDA Warning Letter To India`s Zydus Flags Glass Contamination Concerns
12 Sep 2024 //
ENDPTS
Zydus Lifesciences Gets Warning Letter From USFDA For Jarod Injectable Unit
30 Aug 2024 //
ECONOMICTIMES
FDA issues another Form 483 reprimand for drugmaker Zydus
07 May 2024 //
FIERCE PHARMA
Zydus Lifesciences gets 10 observations from USFDA for Jarod injectable facility
24 Apr 2024 //
INDINPHARMAPOST
Zydus Lifesciences gets 4 observations from USFDA for Gujarat plant
28 Mar 2024 //
BUSINESS STANDARD
Zydus Lifesciences Ahmedabad facility receives 6 observations in recent USFDA inspection
22 Dec 2023 //
CNBCTV18
Zydus unit recalls 7,248 bottles of Oxybutynin Chloride tablets in US
13 Oct 2023 //
ECONOMIC TIMES
Zydus recalls over 55k bottles of generic drug in US
26 Mar 2023 //
ECONOMIC TIMES
FDA makes four Form 483 observations at Zydus Lifesciences facility
09 Aug 2022 //
BUSINESS TODAY
Cadila`s sterile injectable site in India hit with a Form 483
22 Mar 2022 //
ENDPTS
Indian drug firms recall various products in US market
13 Nov 2020 //
TRIBUNEINDIA
India bans export of drug being tested for coronavirus treatment
25 Mar 2020 //
REUTERS
Cadila Healthcare gets EIR from USFDA for its Ahmedabad facility
10 Feb 2020 //
ECONIMIC TIMES
Cadila Healthcare gets EIR from USFDA for its Ahmedabad facility
10 Feb 2020 //
ECONIMIC TIMES
Cadila Healthcare gets EIR from USFDA for its Ahmedabad facility
10 Feb 2020 //
ECONIMIC TIMES
Cadila gains after USFDA concludes plant inspection with no observations
21 Dec 2019 //
BUSINESS STANDARD
FDA orders Cadila to clean up its act at sterile plant in India
13 Nov 2019 //
FIERCE PHARMA
FDA hits Zydus Cadila plant with another warning letter
12 Nov 2019 //
IN PHARMATECHNOLOGIST
New FDA warning letters show India’s drugmakers still in trouble
06 Nov 2019 //
ECONOMIC TIMES
Zydus Cadila injectables plant slapped with FDA warning letter over contamination risks
05 Nov 2019 //
FIERCEP PHARMA
Zydus Cadila gets EIR from USFDA for Ankleshwar facility
24 Sep 2019 //
ECONOMICTIMES
FDA 483s Pile Up in Crackdown on Sartan Manufacturers in India
18 May 2019 //
RAPS
CLSA downgrades Cadila Healthcare to `sell`
14 May 2019 //
ECONOMIC TIMES
Cadila Moraiya plant hit with 14 observations
06 May 2019 //
FIERCE PHARMA
Cadila Healthcare says FDA inspection had no observations
29 Mar 2018 //
FIERCE PHARMA
Cadila says Moraiya drug plant has passed US FDA inspection
08 Sep 2017 //
IN PHARMATECHNOLOGIST
USFDA audit finds no flaws in Cadila Healthcare Moraiya unit
22 Jun 2017 //
BUSINESS-STANDARD
NPPA`s drug overcharging penalty at a record high
11 Mar 2017 //
BUSINESS STANDARD
Top pharma cos overcharging, NPPA lists 634 drugs for breaching price cap
27 Feb 2017 //
BUSINESS STANDARD
Another US warning on Indian drugs
25 Feb 2017 //
BUSINESS STANDARD
US FDA Pulls up Cadila for Misbranding Drug
29 Dec 2016 //
ECONOMIC TIMES
USFDA to re-inspect Cadila Healthcare`s unit
08 Dec 2016 //
ECONOMIC TIMES
Three Made in India drugs recalled in US: FDA
07 Dec 2016 //
DECCAN HERALD
Sun Pharma, Cadila Healthcare Recall Products from US Market
01 Dec 2016 //
BUSINESS STANDARD
Vietnam bans 39 Indian drug firms
22 Nov 2016 //
ECONOMIC TIMES
Sun will recall 31,762 bottles of anti-depressant
12 Oct 2016 //
BUSINESS STANDARD
Aurobindo Pharma, Cadila recall drugs from US market
21 Sep 2016 //
ECONOMICTIMES
Make In India: Pharma entrepreneurs urge industry to address compliance issues
16 Feb 2016 //
ECONOMIC TIMES
